Properties
Description
Trametinib prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
Molecular Formula
C28H29FIN5O5S
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Trametinib can be used to investigate the inhibition of MEK1/2 in cancer research and its therapeutic applications.
